Laquita Jones is an Oncology physician affiliated with Cincinnati Children's Hospital Medical Center. OpenAlex indexes 19 publications with 320 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3333 Burnet Ave
Cincinnati, OH 45229
Telephone
513-636-4200Registry record last updated 16 Aug 2018.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- JAZZ PHARMACEUTICALS INC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- Kinase-independent mechanism of resistance to FLT3 inhibitors in AML
Cincinnati Childrens Hosp Med Ctr
FY2026$262,179K08CA270305 - Kinase-independent mechanism of resistance to FLT3 inhibitors in AML
Cincinnati Childrens Hosp Med Ctr
FY2025$262,179K08CA270305 - Kinase-independent mechanism of resistance to FLT3 inhibitors in AML
Cincinnati Childrens Hosp Med Ctr
FY2024$262,179K08CA270305
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- IRAK1/4/pan-FLT3 Kinase Inhibitors with Reduced hERG Block as Treatments for Acute Myeloid Leukemia
ACS Medicinal Chemistry Letters
2025 - Discovery of IRAK1/4/pan-FLT3 Kinase Inhibitors as Treatments for Acute Myeloid Leukemia
ACS Medicinal Chemistry Letters
2024 - Effect of osteopathic manipulative treatment on pulmonary function testing in children with asthma
Journal of Osteopathic Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Rothenberg, MD
Cincinnati Children's Hospital Medical Center
Prasad Devarajan, MD
Cincinnati Children's Hospital Medical Center
Stuart Goldstein, MD
Cincinnati Children's Hospital Medical Center
Andrew Redington
Cincinnati Children's Hospital Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”